Literature DB >> 10673327

In vivo protection of nigral dopamine neurons by lentiviral gene transfer of the novel GDNF-family member neublastin/artemin.

C Rosenblad1, M Grønborg, C Hansen, N Blom, M Meyer, J Johansen, L Dagø, D Kirik, U A Patel, C Lundberg, D Trono, A Björklund, T E Johansen.   

Abstract

The glial cell line-derived neurotrophic factor (GDNF)-family of neurotrophic factors consisted until recently of three members, GDNF, neurturin, and persephin. We describe here the cloning of a new GDNF-family member, neublastin (NBN), identical to artemin (ART), recently published (Baloh et al., 1998). Addition of NBN/ART to cultures of fetal mesencephalic dopamine (DA) neurons increased the number of surviving tyrosine hydroxylase (TH)-immunoreactive neurons by approximately 70%, similar to the maximal effect obtained with GDNF. To investigate the neuroprotective effects in vivo, lentiviral vectors carrying the cDNA for NBN/ART or GDNF were injected into the striatum and ventral midbrain. Three weeks after an intrastriatal 6-hydroxydopamine lesion only about 20% of the nigral DA neurons were left in the control group, while 80-90% of the DA neurons remained in the NBN/ART and GDNF treatment groups, and the striatal TH-immunoreactive innervation was partly spared. We conclude that NBN/ART, similarly to GDNF, is a potent neuroprotective factor for the nigrostriatal DA neurons in vivo. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10673327     DOI: 10.1006/mcne.1999.0817

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  24 in total

Review 1.  Lentiviral vector-mediated gene transfer and RNA silencing technology in neuronal dysfunctions.

Authors:  Jean-Luc Dreyer
Journal:  Mol Biotechnol       Date:  2011-02       Impact factor: 2.695

2.  Lentiviral vectors for the central nervous system.

Authors:  Elena Armandola
Journal:  MedGenMed       Date:  2004-09-24

3.  Investigating the Role of Artemin Glycosylation.

Authors:  Qiu Danwen; Christian Code; Chao Quan; Bang-Jin Gong; Joseph Arndt; Blake Pepinsky; Kasper D Rand; Damian Houde
Journal:  Pharm Res       Date:  2016-02-23       Impact factor: 4.200

4.  Pseudotype-dependent lentiviral transduction of astrocytes or neurons in the rat substantia nigra.

Authors:  Jason R Cannon; Thomas Sew; Laura Montero; Edward A Burton; J Timothy Greenamyre
Journal:  Exp Neurol       Date:  2010-11-05       Impact factor: 5.330

Review 5.  Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease.

Authors:  Tiago Martins Rodrigues; André Jerónimo-Santos; Tiago Fleming Outeiro; Ana Maria Sebastião; Maria José Diógenes
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

Review 6.  Treatment of Parkinson's disease : what's on the horizon?

Authors:  Stacy S Wu; Steven J Frucht
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

7.  Rac1 is a critical mediator of endothelium-derived neurotrophic activity.

Authors:  Naoki Sawada; Hyung-Hwan Kim; Michael A Moskowitz; James K Liao
Journal:  Sci Signal       Date:  2009-03-10       Impact factor: 8.192

8.  Intranigral lentiviral delivery of dominant-negative TNF attenuates neurodegeneration and behavioral deficits in hemiparkinsonian rats.

Authors:  Melissa K McCoy; Kelly A Ruhn; Terina N Martinez; Fiona E McAlpine; Armin Blesch; Malú G Tansey
Journal:  Mol Ther       Date:  2008-07-15       Impact factor: 11.454

9.  Overexpression of glial cell line-derived neurotrophic factor using a lentiviral vector induces time- and dose-dependent downregulation of tyrosine hydroxylase in the intact nigrostriatal dopamine system.

Authors:  Biljana Georgievska; Deniz Kirik; Anders Björklund
Journal:  J Neurosci       Date:  2004-07-21       Impact factor: 6.167

10.  Lentivirus-mediated delivery of sonic hedgehog into the striatum stimulates neuroregeneration in a rat model of Parkinson disease.

Authors:  Yi Zhang; Weiren Dong; Suiqun Guo; Shu Zhao; Suifen He; Lihua Zhang; Yinjuan Tang; Haihong Wang
Journal:  Neurol Sci       Date:  2014-07-17       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.